-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Lifesci Capital Weighs in on TARS Q1 Earnings
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities research analysts at Lifesci Capital issued their Q1 2025 earnings estimates for Tarsus Pharmaceuticals in a research note issued to investors on Wednesday, February 26th. Lifesci Capital analyst C. Jubinville expects that the company will post earnings of ($0.78) per share for the quarter. The consensus […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities research analysts at Lifesci Capital issued their Q1 2025 earnings estimates for Tarsus Pharmaceuticals in a research note issued to investors on Wednesday, February 26th. Lifesci Capital analyst C. Jubinville expects that the company will post earnings of ($0.78) per share for the quarter. The consensus […]
